Lemaitre Vascular LMAT
NASDAQ LMAT
$78.74 -0.73 (-0.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Lemaitre Vascular (LMAT) EBT Margin Growth (1y) (2011 - 2026)

Analysis

Lemaitre Vascular (LMAT) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -719.00
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 236.00
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 295.00
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 687.00
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 88.00
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 374.00
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -938.00
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 343.00
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 165.00
10 Lemaitre Vascular 1.80 Bn 1.43 Bn 50.76 Mn 339.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 339.00
Mar 31, 2026 577.00
Dec 31, 2025 633.00
Sep 30, 2025 1,043.00
Jun 30, 2025 37.00
Mar 31, 2025 -14.00
Dec 31, 2024 202.00
Sep 30, 2024 582.00
Jun 30, 2024 717.00
Mar 31, 2024 690.00
Dec 31, 2023 410.00
Sep 30, 2023 497.00
Jun 30, 2023 741.00
Mar 31, 2023 -318.00
Dec 31, 2022 -97.00
Sep 30, 2022 -623.00
Jun 30, 2022 -1,253.00
Mar 31, 2022 -67.00
Dec 31, 2021 -377.00
Sep 30, 2021 -377.00